Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-alpha 2a and interleukin-2.

S Morecki; S Revel-Vilk; C Nabet; M Pick; A Ackerstein; A Nagler; E Naparstek; M Ben Shahar; S Slavin

doi:10.1007/BF01789019

Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-alpha 2a and interleukin-2.

Identifier:nobleid.org/w1/20260515/DFCDDA65

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DFCDDA65.svg?ark=w1%2F20260515%2FDFCDDA65)](https://nobleid.org/work/w1/20260515/DFCDDA65)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-alpha 2a and interleukin-2.

Identifier:nobleid.org/w1/20260515/DFCDDA65

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DFCDDA65.svg?ark=w1%2F20260515%2FDFCDDA65)](https://nobleid.org/work/w1/20260515/DFCDDA65)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work